Ecor1 Capital, LLC’s Relay Therapeutics Inc Position
Does Ecor1 Capital, LLC own Relay Therapeutics Inc (RLAY)? Yes — 1.90M shares worth $19M (+0.80% of its 13F portfolio) as of Q1 2026, up from 641.4K shares the prior filed quarter.
Position Value
$19M
Q1 2026
Shares
1.90M
% of Portfolio
+0.80%
Quarters Held
17
currently held
Position History RLAY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.90M | $19M | +0.80% |
| Q1 2025 | 641.4K | $2M | +0.10% |
| Q4 2024 | 641.4K | $3M | +0.10% |
| Q3 2024 | 2.50M | $18M | +0.61% |
| Q3 2023 | 4.16M | $35M | +1.18% |
| Q2 2023 | 4.16M | $52M | +1.28% |
| Q1 2023 | 4.16M | $69M | +2.21% |
| Q4 2022 | 4.16M | $62M | +1.89% |
| Q3 2022 | 4.16M | $93M | +2.75% |
| Q2 2022 | 3.72M | $62M | +2.15% |
| Q1 2022 | 2.29M | $69M | +2.15% |
| Q4 2021 | 1.78M | $55M | +1.74% |
| Q3 2021 | 1.39M | $44M | +1.52% |
| Q2 2021 | 4.49M | $164M | +6.14% |
| Q1 2021 | 3.43M | $119M | +5.26% |
| Q4 2020 | 3.20M | $133M | +7.15% |
| Q3 2020 | 3.20M | $136M | +9.72% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ecor1 Capital, LLC’s full portfolio or all institutional holders of RLAY.